Sears Holdings (NASDAQ:SHLD) has increased its credit facility capacity to
$3.275 billion. Sears Holdings (NASDAQ:SHLD) Increasing Overdraft Sears Holdings
(NASDAQ:SHLD) has announced that it has entered into an amendment to its
domestic revolving credit facility, under which the borrowing capacity of the
company has been increased to $3.275 billion from $2.441 billion. The maturity
date is also extended to April 7, 2016, from June 12, 2012. The facility also
has a lower interest rates and the fee the lender charges Sears Holdings
(NASDAQ:SHLD) for holding available credit was reduced. Sears Holdings
(NASDAQ:SHLD) stocks were at 78.22 at the end of the last days trading. Theres
been a 11.5% change in the stock price over the past 3 months. Sears Holdings
(NASDAQ:SHLD) Analyst Advice Consensus Opinion: Moderate Sell Mean
recommendation: 4 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 4 Zacks Rank: 4
out of 16 in the industry
Monday, April 11, 2011
Stocks Still Can’t Find Footing
Any confirmation needed that a 6% rally in stocks that began a month ago was
getting a little tired was found Monday, with equities retreating to their
lowest close in nearly two weeks. The Dow Jones Industrial Average wound up
gaining a point to finish at 12,381, but the Nasdaq slipped 9 points to 2772 and
the S&P 500 fell 4 points to 1324. As mentioned recently in this space, it was
becoming increasingly clear in the past few trading sessions that the main
drivers of a momentum-based rally small-caps, energy, and large-cap tech were
looking doubtful in their ability to provide any more energy for stocks upside.
And here we went again, with the Russell 2000 falling 0.8% on Monday and
putting up a decline of about 2.5% since Wednesdays close. Similarly, the Nasdaq
100 Index has found itself in a downtrend since the month started, and is in
fact down about 3.5% since hitting its 2011 closing high on Feb. 17. Oil prices
also gave back on Monday, settling under $110 a barrel for the first time since
last Thursday, and sapping the will of traders sifting through small- and
mid-cap energy stocks for one more momentum play. Of course, this meant good
news for airline stocks, which were among the top industry performers of the
day, reversing a 2011 downtrend for at least one day. Shares of Delta Air Lines
(NYSE: DAL ) rose 4.5%, while United Continental (NYSE: UAL ) gained 3.7%.
Perhaps another bright spot for stock optimists was the relative outperformance
by financial stocks, which hadnt joined wholeheartedly in the markets recent
advance. The SPDR Financial Select Sector (NYSE: XLF ) exchange-traded fund
finished precisely flat at $16.46, suggesting that at least in terms of
momentum-based sentiment, there is a bottom potentially in play. Much of that
could be altered by the next several weeks of first-quarter earnings reports,
which should put a little more substance behind what has been a fairly
low-volume rally and drift in stocks. The unofficial first entrant, Alcoa
(NASDAQ: AA ), didnt do much for bulls late Monday, offering a mixed bag
quarterly earnings report that saw the aluminum giant beat profit expectations
but fall short on the top line. More troubling for investors may be in potential
echoes to come from the earnings report late Monday from gaming equipment maker
WMS Industries (NYSE: WMS ), which lowered near-term quarterly forecasts and
said it didnt see much improvement to its industry outlook for this year and
2012. Its that sort of statement that market bulls hope is few and far between
over the next few weeks.
getting a little tired was found Monday, with equities retreating to their
lowest close in nearly two weeks. The Dow Jones Industrial Average wound up
gaining a point to finish at 12,381, but the Nasdaq slipped 9 points to 2772 and
the S&P 500 fell 4 points to 1324. As mentioned recently in this space, it was
becoming increasingly clear in the past few trading sessions that the main
drivers of a momentum-based rally small-caps, energy, and large-cap tech were
looking doubtful in their ability to provide any more energy for stocks upside.
And here we went again, with the Russell 2000 falling 0.8% on Monday and
putting up a decline of about 2.5% since Wednesdays close. Similarly, the Nasdaq
100 Index has found itself in a downtrend since the month started, and is in
fact down about 3.5% since hitting its 2011 closing high on Feb. 17. Oil prices
also gave back on Monday, settling under $110 a barrel for the first time since
last Thursday, and sapping the will of traders sifting through small- and
mid-cap energy stocks for one more momentum play. Of course, this meant good
news for airline stocks, which were among the top industry performers of the
day, reversing a 2011 downtrend for at least one day. Shares of Delta Air Lines
(NYSE: DAL ) rose 4.5%, while United Continental (NYSE: UAL ) gained 3.7%.
Perhaps another bright spot for stock optimists was the relative outperformance
by financial stocks, which hadnt joined wholeheartedly in the markets recent
advance. The SPDR Financial Select Sector (NYSE: XLF ) exchange-traded fund
finished precisely flat at $16.46, suggesting that at least in terms of
momentum-based sentiment, there is a bottom potentially in play. Much of that
could be altered by the next several weeks of first-quarter earnings reports,
which should put a little more substance behind what has been a fairly
low-volume rally and drift in stocks. The unofficial first entrant, Alcoa
(NASDAQ: AA ), didnt do much for bulls late Monday, offering a mixed bag
quarterly earnings report that saw the aluminum giant beat profit expectations
but fall short on the top line. More troubling for investors may be in potential
echoes to come from the earnings report late Monday from gaming equipment maker
WMS Industries (NYSE: WMS ), which lowered near-term quarterly forecasts and
said it didnt see much improvement to its industry outlook for this year and
2012. Its that sort of statement that market bulls hope is few and far between
over the next few weeks.
TODAY’S STOCK MARKET DOW JONES INDUSTRIAL AVERAGE DJI, S&P 500, NASDAQ INDEX TRENDS, NOTES April 11th, 2011 Approaching Close
dow2664
Negocioenlinea
At mid day the major market indexes were all trending in the green. Investors worries were put to ease, at least temporarily, as the federal government pushed through a last minute budget bill on Friday to avoid a potential shut down. Although the deal was welcomed by many, the budget battles are not over as continued controversy over debt ceilings and deficits continue to be debated. With little on the economic calendar for today investors will focus on corporate reports from the first quarter reporting period. Alcoa is scheduled to be the first Dow stock to issue results after the closing bell today. Alcoa will be followed by JPMorgan and Google who are also set to release results later this week. As of close, the market indexes are trending mixed. The Dow was just green at 12,381.11 for the day. The Nasdaq was red at 2,7771.51 to finished and the S&P 500 was red to finish at 1,324.46. Approaching close, the Treasuries 10 year yield was down 0.0020 to 3.57%. Oil prices pull back with a decline of 0.53 to $109.76 a barrel. Gold declined by 0.31% to 1463.40. The U.S. Dollar gained 0.0025 to the Euro. Strong sectors include: office electronics, agricultural chemicals, agricultural products, education services, biotech, life and health insurers. Author: Pamela Frost
Top 10 Solar Stocks with Highest Upside: DSTI, ESLR, ASTI, RSOL, DQ, WEST, SOL, BTUI, JKS, HSOL (Apr 11, 2011)
Below are the top 10 Solar stocks with highest upside potential, UPDATED TODAY
before 4:30 AM ET, based on the difference between current price and Wall Street
analysts average target price. Four Chinese companies (DQ, SOL, JKS, HSOL) are
on the list. DayStar Technologies Inc. (NASDAQ:DSTI) has the 1st highest upside
potential in this segment of the market. Its upside is 468.2%. Its consensus
target price is $5.00 based on the average of all estimates. Evergreen Solar,
Inc. (NASDAQ:ESLR) has the 2nd highest upside potential in this segment of the
market. Its upside is 340.2%. Its consensus target price is $5.94 based on the
average of all estimates. Ascent Solar Technologies, Inc. (NASDAQ:ASTI) has the
3rd highest upside potential in this segment of the market. Its upside is
108.3%. Its consensus target price is $3.38 based on the average of all
estimates. Real Goods Solar, Inc. (NASDAQ:RSOL) has the 4th highest upside
potential in this segment of the market. Its upside is 73.1%. Its consensus
target price is $4.50 based on the average of all estimates. Daqo New Energy
Corp. (NYSE:DQ) has the 5th highest upside potential in this segment of the
market. Its upside is 65.1%. Its consensus target price is $19.33 based on the
average of all estimates. Akeena Solar, Inc. (NASDAQ:WEST) has the 6th highest
upside potential in this segment of the market. Its upside is 62.6%. Its
consensus target price is $0.75 based on the average of all estimates. ReneSola
Ltd. (ADR) (NYSE:SOL) has the 7th highest upside potential in this segment of
the market. Its upside is 48.7%. Its consensus target price is $14.56 based on
the average of all estimates. BTU International, Inc. (NASDAQ:BTUI) has the 8th
highest upside potential in this segment of the market. Its upside is 41.1%. Its
consensus target price is $16.00 based on the average of all estimates.
JinkoSolar Holding Co., Ltd. (NYSE:JKS) has the 9th highest upside potential in
this segment of the market. Its upside is 40.4%. Its consensus target price is
$35.44 based on the average of all estimates. Hanwha Solarone Co Ltd
(NASDAQ:HSOL) has the 10th highest upside potential in this segment of the
market. Its upside is 39.3%. Its consensus target price is $10.28 based on the
average of all estimates.
before 4:30 AM ET, based on the difference between current price and Wall Street
analysts average target price. Four Chinese companies (DQ, SOL, JKS, HSOL) are
on the list. DayStar Technologies Inc. (NASDAQ:DSTI) has the 1st highest upside
potential in this segment of the market. Its upside is 468.2%. Its consensus
target price is $5.00 based on the average of all estimates. Evergreen Solar,
Inc. (NASDAQ:ESLR) has the 2nd highest upside potential in this segment of the
market. Its upside is 340.2%. Its consensus target price is $5.94 based on the
average of all estimates. Ascent Solar Technologies, Inc. (NASDAQ:ASTI) has the
3rd highest upside potential in this segment of the market. Its upside is
108.3%. Its consensus target price is $3.38 based on the average of all
estimates. Real Goods Solar, Inc. (NASDAQ:RSOL) has the 4th highest upside
potential in this segment of the market. Its upside is 73.1%. Its consensus
target price is $4.50 based on the average of all estimates. Daqo New Energy
Corp. (NYSE:DQ) has the 5th highest upside potential in this segment of the
market. Its upside is 65.1%. Its consensus target price is $19.33 based on the
average of all estimates. Akeena Solar, Inc. (NASDAQ:WEST) has the 6th highest
upside potential in this segment of the market. Its upside is 62.6%. Its
consensus target price is $0.75 based on the average of all estimates. ReneSola
Ltd. (ADR) (NYSE:SOL) has the 7th highest upside potential in this segment of
the market. Its upside is 48.7%. Its consensus target price is $14.56 based on
the average of all estimates. BTU International, Inc. (NASDAQ:BTUI) has the 8th
highest upside potential in this segment of the market. Its upside is 41.1%. Its
consensus target price is $16.00 based on the average of all estimates.
JinkoSolar Holding Co., Ltd. (NYSE:JKS) has the 9th highest upside potential in
this segment of the market. Its upside is 40.4%. Its consensus target price is
$35.44 based on the average of all estimates. Hanwha Solarone Co Ltd
(NASDAQ:HSOL) has the 10th highest upside potential in this segment of the
market. Its upside is 39.3%. Its consensus target price is $10.28 based on the
average of all estimates.
TODAY’S STOCK MARKET DOW JONES INDUSTRIAL AVERAGE DJI, S&P 500, NASDAQ INDEX TRENDS, NOTES April 11th, 2011 Approaching Close
At mid day the major market indexes were all trending in the green. Investors
worries were put to ease, at least temporarily, as the federal government pushed
through a last minute budget bill on Friday to avoid a potential shut down.
Although the deal was welcomed by many, the budget battles are not over as
continued controversy over debt ceilings and deficits continue to be debated.
With little on the economic calendar for today investors will focus on corporate
reports from the first quarter reporting period. Alcoa is scheduled to be the
first Dow stock to issue results after the closing bell today. Alcoa will be
followed by JPMorgan and Google who are also set to release results later this
week. As of close, the market indexes are trending mixed. The Dow was just green
at 12,381.11 for the day. The Nasdaq was red at 2,7771.51 to finished and the
S&P 500 was red to finish at 1,324.46. Approaching close, the Treasuries 10 year
yield was down 0.0020 to 3.57%. Oil prices pull back with a decline of 0.53 to
$109.76 a barrel. Gold declined by 0.31% to 1463.40. The U.S. Dollar gained
0.0025 to the Euro. Strong sectors include: office electronics, agricultural
chemicals, agricultural products, education services, biotech, life and health
insurers. Author: Pamela Frost
worries were put to ease, at least temporarily, as the federal government pushed
through a last minute budget bill on Friday to avoid a potential shut down.
Although the deal was welcomed by many, the budget battles are not over as
continued controversy over debt ceilings and deficits continue to be debated.
With little on the economic calendar for today investors will focus on corporate
reports from the first quarter reporting period. Alcoa is scheduled to be the
first Dow stock to issue results after the closing bell today. Alcoa will be
followed by JPMorgan and Google who are also set to release results later this
week. As of close, the market indexes are trending mixed. The Dow was just green
at 12,381.11 for the day. The Nasdaq was red at 2,7771.51 to finished and the
S&P 500 was red to finish at 1,324.46. Approaching close, the Treasuries 10 year
yield was down 0.0020 to 3.57%. Oil prices pull back with a decline of 0.53 to
$109.76 a barrel. Gold declined by 0.31% to 1463.40. The U.S. Dollar gained
0.0025 to the Euro. Strong sectors include: office electronics, agricultural
chemicals, agricultural products, education services, biotech, life and health
insurers. Author: Pamela Frost
Top 10 Pharmaceutical Stocks with Highest Upside: MRNA, CYTR, BSPM, PIP, PRAN, CBP, AVNR, GNVC, EPCT, XOMA (Apr 11, 2011)
Below are the top 10 Pharmaceutical stocks with highest upside potential,
UPDATED TODAY before 4:30 AM ET, based on the difference between current price
and Wall Street analysts average target price. One Chinese company (CBP) is on
the list. Marina Biotech, Inc. (NASDAQ:MRNA) has the 1st highest upside
potential in this segment of the market. Its upside is 354.8%. Its consensus
target price is $2.83 based on the average of all estimates. CytRx Corporation
(NASDAQ:CYTR) has the 2nd highest upside potential in this segment of the
market. Its upside is 258.9%. Its consensus target price is $3.00 based on the
average of all estimates. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) has the
3rd highest upside potential in this segment of the market. Its upside is
244.8%. Its consensus target price is $7.00 based on the average of all
estimates. PharmAthene, Inc. (AMEX:PIP) has the 4th highest upside potential in
this segment of the market. Its upside is 238.5%. Its consensus target price is
$11.00 based on the average of all estimates. Prana Biotechnology Limited (ADR)
(NASDAQ:PRAN) has the 5th highest upside potential in this segment of the
market. Its upside is 233.3%. Its consensus target price is $8.00 based on the
average of all estimates. China Botanic Pharmaceutical Inc (AMEX:CBP) has the
6th highest upside potential in this segment of the market. Its upside is
205.0%. Its consensus target price is $4.88 based on the average of all
estimates. AVANIR Pharmaceuticals (NASDAQ:AVNR) has the 7th highest upside
potential in this segment of the market. Its upside is 203.8%. Its consensus
target price is $12.00 based on the average of all estimates. GenVec, Inc.
(NASDAQ:GNVC) has the 8th highest upside potential in this segment of the
market. Its upside is 201.2%. Its consensus target price is $1.13 based on the
average of all estimates. EpiCept Corporation (NASDAQ:EPCT) has the 9th highest
upside potential in this segment of the market. Its upside is 194.1%. Its
consensus target price is $2.00 based on the average of all estimates. XOMA
Limited (NASDAQ:XOMA) has the 10th highest upside potential in this segment of
the market. Its upside is 193.3%. Its consensus target price is $8.80 based on
the average of all estimates.
UPDATED TODAY before 4:30 AM ET, based on the difference between current price
and Wall Street analysts average target price. One Chinese company (CBP) is on
the list. Marina Biotech, Inc. (NASDAQ:MRNA) has the 1st highest upside
potential in this segment of the market. Its upside is 354.8%. Its consensus
target price is $2.83 based on the average of all estimates. CytRx Corporation
(NASDAQ:CYTR) has the 2nd highest upside potential in this segment of the
market. Its upside is 258.9%. Its consensus target price is $3.00 based on the
average of all estimates. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) has the
3rd highest upside potential in this segment of the market. Its upside is
244.8%. Its consensus target price is $7.00 based on the average of all
estimates. PharmAthene, Inc. (AMEX:PIP) has the 4th highest upside potential in
this segment of the market. Its upside is 238.5%. Its consensus target price is
$11.00 based on the average of all estimates. Prana Biotechnology Limited (ADR)
(NASDAQ:PRAN) has the 5th highest upside potential in this segment of the
market. Its upside is 233.3%. Its consensus target price is $8.00 based on the
average of all estimates. China Botanic Pharmaceutical Inc (AMEX:CBP) has the
6th highest upside potential in this segment of the market. Its upside is
205.0%. Its consensus target price is $4.88 based on the average of all
estimates. AVANIR Pharmaceuticals (NASDAQ:AVNR) has the 7th highest upside
potential in this segment of the market. Its upside is 203.8%. Its consensus
target price is $12.00 based on the average of all estimates. GenVec, Inc.
(NASDAQ:GNVC) has the 8th highest upside potential in this segment of the
market. Its upside is 201.2%. Its consensus target price is $1.13 based on the
average of all estimates. EpiCept Corporation (NASDAQ:EPCT) has the 9th highest
upside potential in this segment of the market. Its upside is 194.1%. Its
consensus target price is $2.00 based on the average of all estimates. XOMA
Limited (NASDAQ:XOMA) has the 10th highest upside potential in this segment of
the market. Its upside is 193.3%. Its consensus target price is $8.80 based on
the average of all estimates.
Top 10 Pharmaceutical Stocks with Highest Upside: MRNA, CYTR, BSPM, PIP, PRAN, CBP, AVNR, GNVC, EPCT, XOMA (Apr 11, 2011)
Below are the top 10 Pharmaceutical stocks with highest upside potential, UPDATED TODAY before 4:30 AM ET, based on the difference between current price and Wall Street analysts' average target price. One Chinese company (CBP) is on the list.
Marina Biotech, Inc. (NASDAQ:MRNA) has the 1st highest upside potential in this segment of the market. Its upside is 354.8%. Its consensus target price is $2.83 based on the average of all estimates. CytRx Corporation (NASDAQ:CYTR) has the 2nd highest upside potential in this segment of the market. Its upside is 258.9%. Its consensus target price is $3.00 based on the average of all estimates. Biostar Pharmaceuticals, Inc. (NASDAQ:BSPM) has the 3rd highest upside potential in this segment of the market. Its upside is 244.8%. Its consensus target price is $7.00 based on the average of all estimates. PharmAthene, Inc. (AMEX:PIP) has the 4th highest upside potential in this segment of the market. Its upside is 238.5%. Its consensus target price is $11.00 based on the average of all estimates. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) has the 5th highest upside potential in this segment of the market. Its upside is 233.3%. Its consensus target price is $8.00 based on the average of all estimates.
China Botanic Pharmaceutical Inc (AMEX:CBP) has the 6th highest upside potential in this segment of the market. Its upside is 205.0%. Its consensus target price is $4.88 based on the average of all estimates. AVANIR Pharmaceuticals (NASDAQ:AVNR) has the 7th highest upside potential in this segment of the market. Its upside is 203.8%. Its consensus target price is $12.00 based on the average of all estimates. GenVec, Inc. (NASDAQ:GNVC) has the 8th highest upside potential in this segment of the market. Its upside is 201.2%. Its consensus target price is $1.13 based on the average of all estimates. EpiCept Corporation (NASDAQ:EPCT) has the 9th highest upside potential in this segment of the market. Its upside is 194.1%. Its consensus target price is $2.00 based on the average of all estimates. XOMA Limited (NASDAQ:XOMA) has the 10th highest upside potential in this segment of the market. Its upside is 193.3%. Its consensus target price is $8.80 based on the average of all estimates.
Negocioenlinea
tdp2664
China Analyst
Top 10 Pharmaceutical Stocks with Highest Upside: MRNA, CYTR, BSPM, PIP, PRAN, CBP, AVNR, GNVC, EPCT, XOMA (Apr 11, 2011)
Subscribe to:
Posts (Atom)
LinkWithin
